HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Liu, Y. Articles by Li, Y. Search for Related Content PubMed PubMed Citation Articles by Liu, Y. Articles by Li, Y.

Ann Thorac Surg 2000;69:1402-1407
© 2000 The Society of Thoracic Surgeons

---

Original articles: Cardiovascular

Pulmonary artery perfusion with protective solution reduces lung injury after cardiopulmonary bypass

^a Department of Surgery, FuWai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Address reprint requests to Dr Liu, Department of Surgery, FuWai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
e-mail: wq.lzhm{at}263.net

Background. The inflammatory response and higher temperature of lung tissue during cardiopulmonary bypass can result in lung injury. This study was to evaluate the protective effect of pulmonary perfusion with hypothermic antiinflammatory solution on lung function after cardiopulmonary bypass.

Methods. Twelve adult mongrel dogs were randomly divided into two groups. The procedure was carried out through a midline sternotomy, cardiopulmonary bypass was established using cannulas placed in the ascending aorta, superior vena cava, and right atrium near the entrance of the inferior vena cava. After the ascending aorta was clamped and cardioplegic solution infused, the right lung was perfused through a cannula placed in the right pulmonary artery with 4°C lactated Ringer’s solution in the control group (n = 6) and with 4°C protective solution in the antiinflammation group (n = 6). Antiinflammatory solution consisted of anisodamine, L-arginine, aprotinin, glucose-insulin-potassium, and phosphate buffer. Plasma malondialdehyde, white blood cell counts, and lung function were measured at different time point before and after cardiopulmonary bypass; lung biopsies were also taken.

Results. Peak airway pressure increased dramatically in the control group after cardiopulmonary bypass when compared with the antiinflammation group at four different time points (24 ± 1, 25 ± 2, 26 ± 2, 27 ± 2 cm H₂O versus 17 ± 2, 18 ± 1, 17 ± 1, 18 ± 1 cm H₂O; all p < 0.01). Pulmonary vascular resistance increased significantly in the control group than in the antiinflammation group at 5 and 60 minutes after cardiopulmonary bypass (1,282 ± 62 dynes · s · cm^-5 versus 845 ± 86 dynes · s · cm^-5 and 1,269 ± 124 dynes · s · cm^-5 versus 852 ± 149 dynes · s · cm^-5, p < 0.05). Right pulmonary venous oxygen tension (PvO₂) in the antiinflammation group was higher than in the control group at 60 minutes after cardiopulmonary bypass (628 ± 33.3 mm Hg versus 393 ± 85.9 mm Hg, p < 0.05). The ratio of white blood cells in the right atrial and the right pulmonary venous blood was lower in the antiinflammation group than in the control group at 5 minutes after the clamp was removed (p < 0.05). Malondialdehyde were lower in the antiinflammation group at 5 and 90 minutes after the clamp was removed (p < 0.01 and p < 0.05, respectively). Histologic examination revealed that the left lung from both groups had marked intraalveolar edema and abundant intraalveolar neutrophils, whereas the right lung in the control group showed moderate injury and the antiinflammation group had normal pulmonary parenchyma.

Conclusions. Pulmonary artery perfusion using hypothermic protective solution can reduce lung injury after cardiopulmonary bypass.

This article has been cited by other articles:

				E. M. Carvalho, E. A Gabriel, and T. A Salerno Pulmonary Protection During Cardiac Surgery: Systematic Literature Review Asian Cardiovasc Thorac Ann, December 1, 2008; 16(6): 503 - 507. [Abstract] [Full Text] [PDF]

				X. Fan, Y. Liu, Q. Wang, C. Yu, B. Wei, and Y. Ruan Lung Perfusion With Clarithromycin Ameliorates Lung Function After Cardiopulmonary Bypass Ann. Thorac. Surg., March 1, 2006; 81(3): 896 - 901. [Abstract] [Full Text] [PDF]

				B. Wei, Y. Liu, Q. Wang, C. Yu, C. Long, Y. Chang, and Y. Ruan Lung perfusion with protective solution relieves lung injury in corrections of Tetralogy of Fallot Ann. Thorac. Surg., March 1, 2004; 77(3): 918 - 924. [Abstract] [Full Text] [PDF]

				J.-H. Zheng, Z.-W. Xu, W. Wang, Z.-M. Jiang, X.-Q. Yu, Z.-K. Su, and W.-X. Ding Lung Perfusion with Oxygenated Blood During Aortic Clamping Prevents Lung Injury Asian Cardiovasc Thorac Ann, March 1, 2004; 12(1): 58 - 60. [Abstract] [Full Text] [PDF]

				W. Eichler, M. J. Bechtel, S. Klaus, M. Heringlake, M. Hernandez, K. Toerber, K.-F. Klotz, and C. Bartels Na+/H+exchange inhibitor cariporide: effects on respiratory dysfunction after cardiopulmonary bypass Perfusion, January 1, 2004; 19(1): 33 - 40. [Abstract] [PDF]

				H.-H Sievers, C. Freund-Kaas, S. Eleftheriadis, T. Fischer, H. Kuppe, E. G. Kraatz, and J.F. M. Bechtel Lung protection during total cardiopulmonary bypass by isolated lung perfusion: preliminary results of a novel perfusion strategy Ann. Thorac. Surg., October 1, 2002; 74(4): 1167 - 1172. [Abstract] [Full Text] [PDF]

				C. S.H. Ng, S. Wan, A. P.C. Yim, and A. A. Arifi Pulmonary Dysfunction After Cardiac Surgery* Chest, April 1, 2002; 121(4): 1269 - 1277. [Abstract] [Full Text] [PDF]